Two new films draw attention to the importance
of treating obesity as a disease and the appropriate use of
anti-obesity medications
INDIANAPOLIS, March 7,
2024 /PRNewswire/ -- Eli Lilly and Company
(NYSE: LLY) today launched the next phase of its Get Better
corporate branding campaign with a new focus on obesity. Earlier
this year, Lilly launched Get Better to reinforce its commitment to
discovering and making medicines that give people a chance at
better health.
As a continuation of the larger campaign, Lilly will air two
films - Shame and Big Night. "These new films
showcase our point of view around obesity—emphasizing our
commitment to patients by highlighting the seriousness of this
disease and the appropriate use of anti-obesity medicines," said
Jennifer Oleksiw, Lilly's Global
Chief Customer Officer. "The overall Lilly Get Better campaign is
aimed at showing who we are – a medicine company that turns science
into healing – since many people may not know us beyond our
individual medicines."
Shame, unveiled during Obesity Care Week, is designed to
increase the dialogue about obesity as a serious disease and
reinforce that there is no place for shame in the conversation
around it. Timed to awards season, the film Big Night
addresses a topic that has been part of the cultural dialogue at
recent high-profile awards ceremonies: the use of anti-obesity
medications outside their FDA-approved indications. Patient safety
is Lilly's top priority, and our medicines are indicated for the
treatment of serious diseases. They were not studied for, are not
approved for, and should not be used for cosmetic weight loss, and
at Lilly we believe it is important that, in consultation with
their healthcare providers, the right people can get access to
these medicines.
Previous films include Get Better and Don't
Forget, focused on Lilly's commitment to Alzheimer's research.
To learn more about Lilly's commitment to patients, visit
Lilly.com.
About Lilly
Lilly is a medicine company turning science into healing to make
life better for people around the world. We've been pioneering
life-changing discoveries for nearly 150 years, and today our
medicines help more than 51 million people across the globe.
Harnessing the power of biotechnology, chemistry and genetic
medicine, our scientists are urgently advancing new discoveries to
solve some of the world's most significant health challenges:
redefining diabetes care; treating obesity and curtailing its most
devastating long-term effects; advancing the fight against
Alzheimer's disease; providing solutions to some of the most
debilitating immune system disorders; and transforming the most
difficult-to-treat cancers into manageable diseases. With each step
toward a healthier world, we're motivated by one thing: making life
better for millions more people. That includes delivering
innovative clinical trials that reflect the diversity of our world
and working to ensure our medicines are accessible and affordable.
To learn more, visit Lilly.com and Lilly.com/news, or follow
us on Facebook, Instagram and LinkedIn. C-LLY
Cautionary Statement Regarding Forward-Looking
Statements
This press release contains forward-looking statements (as that
term is defined in the Private Securities Litigation Reform Act of
1995) about the advertising campaign and reflects Lilly's current
beliefs and expectations. However, there can be no assurance that
the obesity advertising campaign will achieve Lilly's objectives or
that Lilly will execute its strategy as planned. For further
discussion of risks and uncertainties relevant to Lilly's business
that could cause actual results to differ from Lilly's
expectations, see Lilly's Form 10-K and Form 10-Q filings with the
United States Securities and Exchange Commission. Except as
required by law, Lilly undertakes no duty to update forward-looking
statements to reflect events after the date of this release.
#
#
#
Refer to: Molly McCully;
mccully_molly@lilly.com, 317-478-5423
View original content to download
multimedia:https://www.prnewswire.com/news-releases/lillys-newest-phase-of-get-better-campaign-challenges-misperceptions-about-obesity-care-302082242.html
SOURCE Eli Lilly and Company